Healthy men help test drug interaction in Early-Stage trial
NCT ID NCT05723874
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 17 times
Summary
This early-stage trial looked at how taking multiple doses of bosentan changes the amount of BI 425809 in the blood of 14 healthy men. The goal was to measure drug levels, not to treat any disease. Results will help guide future dosing of BI 425809 when used with bosentan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
Conditions
Explore the condition pages connected to this study.